Ramey & Browning wishes to congratulate its client Star Biologics on the issuance of U.S. Patent Number 8,828,958, titled Single-Stranded Oligonucleotides and Uses Thereof. The patent relates to oligonucleotide sequences that either kill or inhibit growth, or prevent the production of endogenously expressed toxin, of microorganisms.
There are no comments for this post. Be the first and Add your Comment below.
Leave a Comment